Diagonal Bio AB Company Description

Diagonal Bio AB (publ) operates as a biotechnology company in Sweden.

The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria.

It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor’s office, surgery, mobile clinics, hospital bedsides, and workplaces and airports.

The company was incorporated in 2020 and is based in Lund, Sweden.

Diagonal Bio AB (publ)

Country	Sweden
Founded	2020
Industry	Biotechnology
Sector	Healthcare
Employees	5
CEO	Karin Wehlin

Contact Details

Address: The Spark Lund, 223 81 Sweden
Phone	46 7 03 05 24 88
Website	diagonalbio.com

Stock Details

Ticker Symbol	DIABIO
Exchange	Nordic Growth Market
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0015961826
SIC Code	2835

Key Executives

Name	Position
Karin Wehlin MBA	Chief Executive Officer
Kushagr Punyani	Tech Advisor, Founding Partner and Director
Andreas Nyberg	Founder and Chief Scientific Officer
Johan Kallstrand	Founding Partner
Fata Mrsic	Chief Financial Officer